Buffer substitution in malaria rapid diagnostic tests causes false-positive results by Gillet, Philippe et al.
METHODOLOGY Open Access
Buffer substitution in malaria rapid diagnostic
tests causes false-positive results
Philippe Gillet
1*, Marcella Mori
1, Jef Van den Ende
1, Jan Jacobs
1,2
Abstract
Background: Malaria rapid diagnostic tests (RDTs) are kits that generally include 20 to 25 test strips or cassettes,
but only a single buffer vial. In field settings, laboratory staff occasionally uses saline, distilled water (liquids for
parenteral drugs dilution) or tap water as substitutes for the RDT kit’s buffer to compensate for the loss of a diluent
bottle. The present study assessed the effect of buffer substitution on the RDT results.
Methods: Twenty-seven RDT brands were run with EDTA-blood samples of five malaria-free subjects, who were
negative for rheumatoid factor and antinuclear antibodies. Saline, distilled water and tap water were used as
substitute liquids. RDTs were also run with distilled water, without adding blood. Results were compared to those
obtained with the RDT kit’s buffer and Plasmodium positive samples.
Results: Only eight cassettes (in four RDT brands) showed no control line and were considered invalid. Visible test
lines occurred for at least one malaria-free sample and one of the substitutes in 20/27 (74%) RDT brands (saline: n
= 16; distilled water: n = 17; and tap water: n = 20), and in 15 RDTs which were run with distilled water only. They
occurred for all Plasmodium antigens and RDT formats (two-, three- and four-band RDTs). Clearance of the
background of the strip was excellent except for saline. The aspects (colour, intensity and crispness) of the control
and the false-positive test lines were similar to those obtained with the RDT kits’ buffer and Plasmodium positive
samples.
Conclusion: Replacement of the RDT kit’s dedicated buffer by saline, distilled water and tap water can cause false-
positive test results.
Background
The use of malaria RDTs is rapidly expanding
Malaria rapid diagnostic tests (RDTs) detect Plasmo-
dium parasites in blood by an antibody-antigen reaction
on a nitrocellulose strip. Reactions are visible as cherry-
red lines. Two-band RDTs are mostly designed to detect
Plasmodium falciparum; they display a control line and
a test line, which targets either histidine-rich protein-2
(HRP-2) or P. falciparum-specific parasite lactate dehy-
drogenase (Pf-pLDH). Three- and four-band RDTs dis-
p l a yac o n t r o ll i n ea n dt w oo rt h r e et e s tl i n e s ,o n e
targeting P. falciparum specific antigen, another line tar-
geting antigens common to the four species, such as
pan-Plasmodium-specific lactate parasite dehydrogenase
(pan-pLDH) or aldolase, and, in case of the four band
RDTs, a third line which targets Plasmodium vivax-
specific pLDH (Pv-pLDH).
RDTs are currently rolled out by national malaria con-
trol programmes in endemic settings as a tool for para-
site based diagnosis in the scope of artemisinin-based
combination therapy (ACT) [1]. In 2007, more than
70,000,000 tests were performed [2]. During the last few
years, RDTs have technically improved and so-called
one-step tests have replaced the older multistep tests.
However, despite their apparent simplicity, they are not
completely fail-proof [3,4].
The single vial of buffer in RDT kits may cause problems
of availability
Most malaria RDTs are marketed as kits that include
material for 20 to 25 tests, such as lancets for finger
pricking, test strips (available as dipstick, cassette or
card box formats), transfer devices (pipettes, straws,
capillaries or loops) and the buffer. Cassettes are usually
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transfer devices match the number of cassettes. All
RDTs need a buffer to lyse the blood and to allow capil-
lary flow along the nitrocellulose strip. Mostly, this buf-
fer is supplied in a single bottle or dropper vial.
During field visits (particularly in Africa, ITM teams
repeatedly observe availability problems of buffer vial:
for instance, some cassettes were sent for testing in the
ward, but the buffer vial did not return. To compensate,
laboratory technicians took either a buffer vial from
another kit (sometimes a kit of another brand), or used
saline, distilled water (liquids for parenteral drugs dilu-
tion) and occasionally tap water as substitute liquids.
Apparently, this substitution for the buffer seemed not
to cause too much interference, as in all observed cases,
there was enough background clearance and both con-
trol line and test lines were clearly distinguishable.
This phenomenon was also noted during a practical
teaching session at the Institute of Tropical Medicine
(ITM): students and staff were astonished to observe a
visible HRP-2 line when the blood of one of the present
authors (PG) was tested with a two-band RDT which
was run with distilled water. PG had no symptoms of
malaria, nor did he suffer from malaria in the recent
past. When performing the RDT with the kit’s dedicated
buffer, there was no HRP-2 line visible. The HRP-2 line
appeared upon retesting with distilled water and also
when using saline and tap water as substitute liquids. As
false-positive test line seemed to be the explanation, it
was decided to explore this phenomenon.
Methods
Samples of healthy subjects and Plasmodium positive
samples
EDTA-blood samples from five healthy subjects with no
recent history of malaria were used. For all samples, the
diagnosis of malaria was excluded by microscopy and
species-specific PCR as previously described [5,6]. The
presence of known causes of false positive RDT results
such as the rheumatoid factor or antinuclear antibodies
was ruled out [7-9] and none of the subjects had been
manipulating mice during the past ten years, thereby
reducing the probability of false positive results due to
anti-mouse antibodies [10]. For most experiments, fresh
samples were used; samples stored at -70°C were used
in the case of delays of delivering of the RDTs. For com-
parison, all RDTs were run with their kit’s dedicated
buffer and two clinical samples, one infected with P.
falciparum and another with P. vivax, at parasite densi-
ties of 36,140 and 3,600/μl respectively.
Choice of malaria RDTs
Malaria RDTs marketed as cassettes and folded card box
were selected, and RDT brands commonly used in field
settings were included. CE marking and FDA approval
of the RDTs were recorded, as well as their presence on
the World Health Organization (WHO) lists of RDT
manufacturers and distributors complying with
ISO13485:2003 or US FDA 21 CFR 820 production
norms and their evaluation by the World Health Orga-
nization/Foundation for Innovative New Diagnostics
(WHO/FIND) [11,12]. RDTs that were not on the local
(Belgian) market were directly ordered from the manu-
facturer. In view of the wide lot-to-lot variations and the
ever changing composition of RDTs, it was decided not
to display the individual RDT brand and kit names, in
line with previous comparative studies assessing charac-
teristics of RDTs [13,14].
RDT test procedures
All RDT kits were used within their expiry date and had
been stored at room temperature (maximum 25°C)
before analysis. RDTs were assessed in the same run
with the five subjects’ blood and the following buffers:
RDT kit’s dedicated buffer, distilled water (Denolin,
Brussels, Belgium), saline (NaCl 0.9%, Qualiphar, Bor-
nem Belgium) and tap water from local supply. For each
RDT and substitute liquid, the blood samples of all five
subjects were used except when a particular RDT kit
was finished. In addition, tests were run in the absence
of blood, with distilled water as the substitute liquid.
All tests were performed according to the instructions
of the manufacturer, except that samples were loaded
with a pipette (Finnpipette, Helsinki, Finland) instead of
the transfer device supplied by the manufacturer. Read-
ings were performed by three readers at daylight assisted
b yas t a n d a r de l e c t r i cb u l b ,a n dw i t h i na n dn o tb e y o n d
the prescribed delay after application of the sample and
buffer.
Interpretation of results
In case the control line did not appear, the result was
considered as invalid and the test was repeated. RDT
test lines were interpreted according to the manufac-
turers’ instructions. In addition, test line intensities were
scored into five categories: none (no line visible), faint
(barely visible line), weak (paler than the control line),
medium (equal to the control line) or strong (stronger
than the control line) [6]. Observers were blinded to
each others’ reading. The results of the readings consid-
ered were based on consensus agreement [15].
The appearance, shape and crispness of the control
and test lines and the clearance of the background were
compared with those obtained with the RDT kit’sd e d i -
cated buffer and the two Plasmodium-positive samples.
Visible test lines observed in the malaria free subjects’
samples will be further referred to as “false-positive test
lines”.
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Inter-reader reliability was assessed and expressed as
percentage agreements for all three readers and kappa
values for each pair of readers. To assess test reproduci-
bility, a sample from one subject was tested upon five
occasions for all RDT brands and the three substitute
liquids. Two RDT brands were not included in the
reproducibility assessment because of shortage of tests.
Ethical review
The study was approved by the Institutional Review
Board of ITM and by the Ethical Committee of Antwerp
University, Belgium.
Results
Selection of malaria rapid diagnostic kits
Thirty different RDT brands were selected. As two
brands from the same manufacturer showed bad
clearance of the background upon testing with Plasmo-
dium-positive samples and another brand had a very
low specificity, they were not included in the study. The
final panel consisted of 27 brands (26 cassette and 1
card box format). Eleven (40.7%) of them had CE-mark
compliance, one was approved by the U.S. Food and
Drug Administration, 22 (81.5%) were included in the
WHO list of RDTs adequate evidence of good manufac-
turing practice (GMP), 22 (81.5%) were evaluated by the
WHO/FIND [11,12], and 9 (30%) are included in the list
of malaria RDTs eligible for procurement by WHO [16].
The 27 RDT brands comprised two-, three- and four-
band RDTs (Table 1) and all Plasmodium target
antigens (HRP-2, Pf-pLDH, Pv-pLDH, pan-pLDH and
aldolase) (Table 2).
Results for the RDTs when run with samples of malaria
free subjects and substitute liquids
When run with their kit’s buffer, none of the RDT
brands tested positive with any of the samples of the
five malaria free subjects. Likewise, when tested with
the two Plasmodium positive blood samples and the
RDT kit’s buffer, the expected test line results were
observed.
When tested with a substitute liquid, there were eight
invalid test results; they neither showed a control line
upon repetition. Five of them occurred in a single RDT
brand when assessed with distilled water. False-positive
test lines were visible for at least one sample and substi-
tute liquid in 20/27 (74%) RDT brands, at the following
frequencies: saline: n = 16, distilled water n = 17 and
tap water: n = 20 (Table 1). They occurred randomly
among the samples of the five malaria free subjects, and
occurred in at least three of them. For 10 RDT brands,
all five blood samples tested positive with at least one of
the substitute liquids (saline: n = 4, distilled water: n =
5, tap water: n = 7). Two-, three- and four-band RDTs
were all affected, as well as all Plasmodium target anti-
gens (Table 2).
For distilled water and tap water as the substitute
liquid, the RDT strips with false-positive lines showed a
clearance of background similar to those observed with
the RDT kit’s buffer. In the case of saline, the back-
ground was less clear. Overall, the colour and crispness
of the control and false-positive test lines were similar
to those obtained with the RDT kits’ buffers and Plas-
modium positive samples (Figure 1 and 2). The propor-
tions of medium and strong line intensities for all
substitute liquids combined were as follows: 26.7% (23/
86) for HRP-2, 11.5% (3/26) for Pf-pLDH, 37.7% (20/53)
for Pv-pLDH and 29.6% (26/88) for pan-pLDH. All false
positive aldolase lines (n = 11) were either faint or
weak. To the exception of better clearance of the back-
ground, the use of frozen sample did not influence the
outcome of the results.
Results for the RDTs when run with distilled water only
When tested with distilled water in the absence of
blood, there was only a single invalid cassette, in which
neither a control line appeared upon retesting. Control
lines were observed in all remaining runs. Twenty-two
false positive test lines were observed in 15 (55.6%) RDT
brands and occurred in all Plasmodium targets (Table
3). Control and false positive test lines showed colour,
thickness and crispness similar to those obtained with
the RDT kits’ buffers and Plasmodium-positive samples
Table 1 Numbers of RDT brands showing false positive test lines when run with blood of malaria free subjects and
substitute liquids
RDT format Numbers of different RDT brands assessed Numbers of RDTs brands showing false positive test lines when run with
substitute liquid*
Saline Distilled water Tap water Any substitute liquid
Two band 6 3 (1) 3 (1) 4 (1) 4 (1)
Three band 17 12 (9) 11 (10) 12 (9) 12 (10)
Four band 4 1 (0) 3 (2) 4 (2) 4 (2)
Total 27 16 (10) 17 (13) 20 (12) 20 (13)
*Numbers refer to the different RDT brands for which false positive test lines were visible in at least one sample. Between brackets: numbers of RDT brands for
which false positive lines were visible in the samples of at least three subjects.
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have however tended to be lower (Table 3).
Inter-reader reliability and reproducibility
The inter-observer agreement for positive and negative
readings was high, with 96.4% overall agreement
between the three observers and kappa values between
0.94-0.98 for each pair out of three observers. Inter-
observer agreements were similar for all three substitute
liquids. Discrepancies between line intensity readings
were limited to one category of line intensity (e.g., line
intensity read as weak by reader one and as medium
(but not strong) by reader two).
At reproducibility testing, false positive test lines
occurred in at least four out of five runs in approxi-
mately half of the Plasmodium targets lines affected
(40.0% (10/25), 51.9% (14/27) and 51.6% (16/31)) for sal-
ine, distilled water and tap water respectively). In terms
of RDT brands, they occurred in at least four runs in
eight, eleven and nine brands for saline, distilled water
and tap water respectively.
Differences between the different RDT brands
CE-mark and non-CE labelled RDT brands were equally
affected by the buffer substitution (11 out of 20, versus
four out of seven). In addition, there were 11/22 WHO-
GMP listed RTD brands affected versus four out of five
RDTs that were not listed, 12/22 FIND evaluated brands
versus three out of seven, and five out of nine RDTs
f r o mt h eW H Op r o c u r e m e n tl i s ta f f e c t e dv e r s u s1 0 / 1 8 .
Although the false-positive test lines occurred randomly
among the different RDT brands, there were certain
RDT brands that were more affected than others.
Discussion
This study shows that replacing malaria RDT kit’sb u f -
fers with saline, distilled water and tap water resulted in
false-positive test lines in the majority of brands
assessed. All Plasmodium targets and RDT formats were
affected, and the control and false positive test lines
observed were similar to those obtained with Plasmo-
dium-positive samples and the RDT kits’ buffers. In
addition, approximately half of the RDT brands showed
false positive test lines when run with distilled water in
the absence of blood.
Malaria RDTs detect Plasmodium antigens by anti-
body-antigen interactions on a nitrocellulose test strip.
The patient’s blood and several drops of buffer are
applied to the sample pad of the strip. They are
attracted by the capillary action of a soak pad at the
other end of the strip and start to migrate. First, they
pass the so-called conjugation pad, which contains a
detection antibody targeted to a Plasmodium antigen,
such as HRP-2, Pf-pLDH, Pv-pLDH, pan-pLDH and
aldolase. This detection antibody is a mouse-antibody
that is conjugated to a signal, mostly colloidal gold. If
present in the sample, the Plasmodium antigen is bound
to this detection antibody-conjugate. The antigen-
antibody-conjugate complex migrates further across the
strip until it is bound to a second antibody, the so-called
capture antibody. This capture antibody reacts to
another epitope of the Plasmodium target antigen. As
the capture antibody is applied on a narrow section of
the strip, the complex with the conjugated signal will be
concentrated and becomes visible as a cherry-red
coloured line. The excess of detection antibody-
conjugate that was not bound by the antigen and the
capture antibody moves further towards the soak pad
until it is bound to a goat anti-mouse antibody, thereby
generating a control line [10,17].
The present study has its limitations. First, there are
currently more than 80 different RDT brands marketed
[1], by consequence the results of the present panel of
27 brands should not be extrapolated to all RDTs. How-
ever, some out of these 80 brands are identical products
marketed either as strips and cassette formats, of which
the cassette form was tested in this study, given the fact
that cassettes proved to be superior in terms of end-
Table 2 Numbers of false-positive test lines for the different Plasmodium antigens of the RDTs when run with blood of
malaria free subjects and substitute liquids
RDT target
antigen
Numbers of RDT brands (n = 27) detecting
the target
Total numbers of tests performed with each
substitute*
Numbers of false positive
test lines when run with
substitute liquid
Saline Distilled
water
Tap
water
HRP-2 21 98 22 28 36
Pf-pLDH 5 25 8 9 9
Pv-pLDH 9 45 12 21 20
Pan-pLDH 14 70 30 25 33
Aldolase 3 11 1 5 5
*Each RDT brand was assessed with blood of five malaria-free subjects except one HRP-2-based kit and one HRP-2/aldolase-based kit that were assessed with
two and one samples respectively.
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RDT brands were elected with a majority of them
included in the WHO-GMP list, evaluated by WHO/
FIND [11,12] or eligible for procurement by WHO [16].
Another limitation is the fact that the presence of anti-
mouse antibodies, which can potentially produce false
positive test lines was not ruled out by serologic testing
[10]. However, none of the subjects reported long-term
contact with mice, and the results obtained with the
RDT kits’ buffer were invariably negative. The most pre-
valent causes of false positive test lines from the sample
side were excluded (rheumatoid factor and anti-nuclear
antibodies) and the recommended reading delays were
carefully respected thereby avoiding the backflow phe-
nomenon: backflow is reverse migration of the antibody-
signal conjugate with nonspecific bindings at the test
line site, it is cited as the most common cause of false-
positive reactions in RDTs [10]. Finally the physico-
chemical causes of the false-positive test lines were not
explored, partly because of technical limitations, partly
because buffer compositions are often proprietary.
The presence of the control line is the result of the
binding of the conjugated mouse-raised detection
Figure 1 Example of buffer substitution’s effect on a three-
band RDT. Three-band RDT cassettes run with blood of a malaria
free subject and the RDT kit’s dedicated buffer (1), injection water
(2), saline (3), tap water (4) and when run with injection water in
absence of blood sample (5). Cassettes “Pf” and “Pv” refer to
Plasmodium falciparum or Plasmodium vivax positive samples run
with the RDT kit’s dedicated buffer. All cassettes show regular
control lines, cassette 1 shows the expected result (no test line
visible), cassettes 2, 3 and 5 show false positive pan-pLDH and Pf-
HRP2 lines, cassette 4 shows a false positive pan-pLDH line, and
cassettes “Pf” and “Pv” show the expected results (positive for pan-
pLDH and Pf-HRP-2 lines or positive for pan-pLDH line respectively).
In the cassette 3, the false positive reaction is partially masked by
the background.
Figure 2 Example of buffer substitution’s effect on a two-band
RDT. Cassettes of a two-band RDT run with blood of a malaria free
subject and the RDT kit’s dedicated buffer (1), injection water (2),
saline (3), tap water (4) and when run with injection water in
absence of blood sample (5). Cassettes “Pf” and “Pv” refer to
Plasmodium falciparum or Plasmodium vivax positive samples run
with the RDT kit’s dedicated buffer. All cassettes show regular
control lines, cassette 1 shows the expected result (no test line
visible), cassettes 2, 3, 4 and 5 show false positive Pf-HRP-2 line,
cassettes “Pf” and “Pv” show the expected results (positive for Pf-
HRP-2 line or no test line visible respectively).
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irrespective of the correct buffer there will be nearly
always a control line visible as long as migration has
been achieved. For the false-positive test lines, the situa-
tion is different. Their scattered distributions within the
five malaria-free subjects and their moderate consistency
upon retesting suggest nonspecific reactions, such as
binding of the negatively charged colloidal gold conju-
gate to the positively charged capture antibodies. As the
false-positive lines also occurred with distilled water in
the absence of blood, a crucial role for the buffer is
apparent. Apart from lysis of the red blood cells and
allowing capillary migration of the sample along the
strip, the buffer has other functions: it re-solubilizes
blocking agents, such as detergents, polymers and pro-
teins on the sample pad and the dried detection anti-
body-colloidal gold conjugate on the conjugate pad.
Further, it ensures optimal pH and ionic strengths for
the antigen-antibody reactions [10,17,21]. Substitution of
the buffer may contribute to the non-specific bindings
of the conjugate to the capture antibody in different
ways: (i) less stringent pH and ionic strength conditions
allowing non-specific bindings, (ii) inefficient solubilisa-
tion of blocking agents from the sample pad and (iii) a
slower capillary flow rate which in turn decreases flush-
ing of the non-specific bindings. Adding to this are
mechanical issues: during application of the capture
antibody, the dispensing pipette may emboss a groove in
the membrane, with an additional decrease in capillary
flow rate [21].
The high amount of false positive test lines with sub-
stitute liquids was unexpected and has, to the best of
our knowledge, not yet been reported. The fact that the
false positive test lines showed colour and crispness
similar to those generated by Plasmodium-positive sam-
ples adds to the problem. In addition, their line intensi-
ties were comparable (albeit somewhat lower) to those
observed in previous RDT evaluations at ITM
[6,15,22-24] and among the affected RDT brands, there
were two-band RDT brands that are currently widely
deployed in endemic field settings.
Although the phenomenon of buffer substitution was
observed in various places and on different occasions,
the real extent of this phenomenon in the field is
unknown. Studies assessing errors made by end-users
do not mention it [20,25] but their designs (observations
by checklists) were not adapted to assess incidental
errors. It is tempting to speculate that at least some of
the reported discrepancies between molecular tests and
results from RDTs in field settings might be attributed
to buffer substitution: as an example, Veron and Carme
reported apparently false-positive RDT results for which
they raised the possibility of incorrect performance [26].
False negative and false positive might delay/or
exclude true diagnosis, with consequences that can go
up to death for patients. The consequences of false-
positive RDTs extend those of individual patient care
and the non-justified prescription of ACT treatment:
like other errors by end-users, poor performance of
RDTs will erode the health care workers’ confidence in
RDT test results thereby hindering the implementation
of RDTs in treatment algorithms and malaria control
programs [2]. Furthermore, as the buffer helps to ensure
optimal conditions of pH and ionic strength, there is
also a concern of possible false-negative results.
Although this was not addressed in the present study,
anecdotal information from colleagues and alumni in
the field indicated also false negative results in case of
simple substitution of the RDT kit’sb u f f e rb yav i a l
from another kit, even from the same brand but from a
different lot. Therefore minimal changes of buffer com-
position seem to cause critical effects. Finally, one might
question whether other rapid diagnostic tests such as
those detecting HIV-antibodies also suffer from this
phenomenon.
Prevention of buffer substitution can be addressed in
several ways. From daily use and evaluations of RDTs, it
is clear that some manufacturers already supply buffer
vials with a volume in excess to the numbers of tests
included. A solution could be the provision of more
than one vial per kit, ideally (if costs are not too high),
small plastic vials dedicated for each individual cassettes,
Table 3 Numbers of false-positive test lines for the different Plasmodium antigens of the RDTs when run with distilled
water in absence of blood sample
RDT target
antigen
Numbers of RDT brands (n = 27) detecting the
target
Numbers of false positive test
lines
Numbers of false positive test
lines according to test line
intensity
Faint Weak Medium Strong
HRP-2 21 11 2 5 3 1
Pf-pLDH 5 2 1 1 0 0
Pv-pLDH 9 1 1 0 0 0
Pan-pLDH 14 6 1 4 1 0
Aldolase 3 2 1 1 0 0
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for self-testing (example: CareStart® Malaria, Single Kit,
Access Bio Inc., New Jersey, USA).
Complementary, RDT package inserts should mention
not to use any other liquids apart from the buffer sup-
plied with the kit. Likewise, the generic job aids on
malaria RDT designed by WHO [27] could include a
comment on the use of the RDT kit’s buffer.
The issue of buffer substitution should further be
addressed in RDT instructions and trainings at all levels
of health care organization. With respect to the organi-
zation of RDT performance by the end users among
health care workers, it is recommended that use of the
correct buffer should be supervised by a laboratory offi-
cer and that the RDT kits’ content should not be split.
Conclusions
In conclusion, buffer substitution in malaria RDTs
causes false positive test lines in the majority of brands
tested. Preventive measures in terms of product design,
packaging, instructions manuals and trainings are
needed to alert for this potential error.
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